血管影像市场规模- 按模式（电脑断层扫描、MRI、超音波、核子医学、X 光）、应用（诊断、治疗）、程序（冠状动脉造影、週边血管造影）、最终用途和全球预测，2024 年- 2032 年

由于新兴经济体为支持开发和采用诊断血管疾病的先进影像技术而增加的医疗保健资金，全球血管影像市场规模从 2024 年到 2032 年将以 5.9% 的复合年增长率扩大。研究人员和医疗保健提供者正在探索新技术并增强现有模式，以提高诊断准确性和患者治疗结果。

正在进行的投资还有助于将先进技术融入日常医疗实践中，以加强医疗基础设施并提高血管健康先进诊断工具的可近性。例如，2023 年 10 月，雅培推出了由 Ultreon 1.0 软体提供支援的新型血管影像平台，以增强医生可视化血流和识别冠状动脉阻塞的能力。

市场分为模式、应用、程序、最终用途和区域。

就模式而言，由于提供血流和血管健康的非侵入性见解的进步，超音波血管成像行业预计到 2032 年将经历显着的增长。超音波被医疗保健专业人员广泛用于诊断深部静脉血栓和动脉狭窄等疾病。超音波技术的不断发展进一步增强了其提高血管成像分辨率和准确性的能力。

按最终用途划分，诊断成像中心领域的血管成像市场预计将从 2024 年到 2032 年增长，因为这些设置采用超音波和 MRI 等各种技术来评估血流并识别血管异常。这些中心正在增强其成像技术，以提高诊断准确性和患者护理。他们还透过整合先进的成像模式来扩展其能力，以实现更精确的血管健康评估。

从地区来看，在政府大力支持和持续医疗改革的带动下，亚太地区血管成像行业规模预计将在 2024 年至 2032 年间出现强劲增长。多项措施正在支持在医疗机构中采用先进的影像技术。在基础设施和培训方面进行了大量投资，以提高血管成像服务的可及性和品质。不断努力将先进成像模式融入常规医疗实践，以确保整个地区诊断能力的提高和患者治疗效果的改善，这将有利于市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 癌症和心臟病的盛行率上升
    • 技术进步与产品创新
    • 对预防保健和疾病筛检计划的认识不断增强
    • 有利的政府倡议
  • 产业陷阱与挑战
    • 增加翻新产品的使用
    • 与产品相关的高成本
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 公司矩阵分析
• 战略展望矩阵

第 5 章：市场估计与预测：按模式，2021 - 2032 年

• 主要趋势
• CT检查
• 核磁共振成像
• 超音波
• 核子医学
• X射线

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 诊断
• 治疗性

第 7 章：市场估计与预测：按程序，2021 - 2032

• 主要趋势
• 冠状动脉造影
• 週边血管摄影
• 神经血管摄影
• 血管超音波
• 显微血管摄影
• 脑血管摄影
• 其他手续

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 诊断影像中心
• 其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Abbott Laboratories
• Carestream Health
• GE HealthCare Technologies Inc.
• Hitachi, Ltd.
• Hologic, Inc.
• Koninklijke Philips N.V.
• SAMSUNG ELECTRONICS Co., Ltd
• Shimadzu Corporation
• Siemens Healthineer AG
• Terumo Corporation

Global Vascular Imaging Market size will expand at 5.9% CAGR from 2024 to 2032 due to increasing healthcare funding in emerging economies for supporting the development and adoption of advanced imaging technologies for diagnosing vascular conditions. Researchers and healthcare providers are exploring new techniques and enhancing existing modalities to improve diagnostic accuracy and patient outcomes.

The ongoing investments are also helping in integrating advanced technologies into routine medical practices to strengthen healthcare infrastructures and enhance accessibility to advanced diagnostic tools for vascular health. For instance, in October 2023, Abbott introduced its new vascular imaging platform powered by Ultreon 1.0 Software for enhancing the ability of physicians to visualize blood flow and identify coronary artery blockages.

The market is segregated into modality, application, procedure, end-use, and region.

In terms of modality, the ultrasound vascular imaging industry is set to experience significant growth rate through 2032 due to advancements for providing non-invasive insights into blood flow and vascular health. Ultrasound is widely used by healthcare professionals for diagnosing conditions, such as deep vein thrombosis and arterial stenosis. The increasing developments in ultrasound technology are further enhancing its capabilities for improving resolution and accuracy in vascular imaging.

By end-use, the vascular imaging market from the diagnostic imaging centres segment is projected to rise from 2024 to 2032, as these settings employ various techniques, such as ultrasound and MRI to assess blood flow and identify vascular abnormalities. These centers are enhancing their imaging technologies to improve diagnostic accuracy and patient care. They are also expanding their capabilities by integrating advanced imaging modalities for enabling more precise assessments of vascular health.

Regionally, the Asia Pacific vascular imaging industry size is projected to depict robust growth between 2024 and 2032, led by the surging government support and ongoing healthcare reforms. Several initiatives are supporting the adoption of advanced imaging technologies across healthcare facilities. There have been significant investments in infrastructure and training to enhance the accessibility and quality of vascular imaging services. Rising efforts for integrating advanced imaging modalities into routine medical practices for ensuring improved diagnostic capabilities and better patient outcomes across the region will favor the market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of cancer and cardiac diseases
    • 3.2.1.2 Technological advances and innovation in products
    • 3.2.1.3 Growing awareness towards preventive healthcare and disease screening programs
    • 3.2.1.4 Favorable government initiatives
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Increasing use of refurbished products
    • 3.2.2.2 High cost associated with the products
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Company matrix analysis
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Computed tomography
• 5.3 MRI
• 5.4 Ultrasound
• 5.5 Nuclear medicine
• 5.6 X-Ray

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Diagnostic
• 6.3 Therapeutic

Chapter 7 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Coronary angiography
• 7.3 Peripheral angiography
• 7.4 Neurovascular angiography
• 7.5 Vascular ultrasound
• 7.6 Microangiography
• 7.7 Cerebral angiography
• 7.8 Other procedures

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Diagnostic imaging centers
• 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 Carestream Health
• 10.3 GE HealthCare Technologies Inc.
• 10.4 Hitachi, Ltd.
• 10.5 Hologic, Inc.
• 10.6 Koninklijke Philips N.V.
• 10.7 SAMSUNG ELECTRONICS Co., Ltd
• 10.8 Shimadzu Corporation
• 10.9 Siemens Healthineer AG
• 10.10 Terumo Corporation